Library

Adverse Effects of Vaccines / Kathleen Stratton / Washington, D.C. : National Academy Press (2011)  

Adverse Effects of Vaccines : Evidence and Causality [printed text] / Kathleen Stratton, Author ; Andrew Ford, Author ; Erin Rusch, Author ; Ellen Wright Clayton, Author . - Washington, D.C. : National Academy Press, 2011 . - 800 p. : ill. ; A5. ISBN : 978-0-309-21435-3 : $ 72,86 Languages : English (eng) Descriptors: Indexation Electronic books ; Encephalitis, Varicella Zoster ; Epidemiology ; Evidence-Based Practice ; Influenza Vaccines ; Papillomavirus Vaccines ; United States ; Vaccines Classification QW 805 Vaccines. Antitoxins. Toxoids Abstract: In 1900, for every 1000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The cornerstone of the vaccine safety system in the United States is the National Childhood Vaccine Injury Act. This legislation was intended to bolster vaccine research and development through federal coordination of vaccine initiatives, and by providing relief to vaccine manufacturers facing financial burdens. A key component of the legislation required the Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse effects, especially in children. The Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological evidence regarding adverse health effects associated with specific vaccines covered by the Vaccine Injury Compensation Program including varicella zoster vaccine, influenza vaccines, hepatitis B vaccine, and the human papillomavirus vaccine, among others. For each possible adverse event, the report reviews prior studies, summarizes their findings, and evaluates the epidemiological evidence. It finds that while no vaccine is 100% safe, very few adverse events are shown to be caused by vaccines. In addition, the evidence shows that vaccines do not cause several conditions of recent concern. For example, the MMR vaccine is not associated with autism or childhood diabetes. The DTaP vaccine is also not associated with diabetes and the influenza vaccine given as a shot does not exacerbate asthma. The Adverse Effects of Vaccines will be of special interest to the National Vaccine Program Office, the Centers for Disease Control and Prevention, vaccine safety researchers and manufacturers, parents, caregivers, and health professionals in the private and public sectors. Contents note: SUMMARY 1 -- Charge to the Committee 2 -- Assessing the Weight of Evidence 2 -- Causality Assessment 5 -- Causality Conclusions 7 -- Susceptibility 9 -- Concluding Comment 9 -- References 24 -- 1 INTRODUCTION 25 -- Charge to the Committee 27 -- Committee Process 28 -- Outline of the Report 28 -- References 33 -- 2 APPROACH 35 -- Literature Searching 35 -- Weight of Evidence 36 -- Causality Assessment 41 -- Special Considerations 45 -- References 48 -- 3 EVALUATING BIOLOGICAL MECHANISMS OF ADVERSE EVENTS 51 -- Latency Between Antigen Exposure and Peak Adaptive Immune Response 51 -- Immune-Mediated Mechanisms 52 -- Viral Activity 66 -- Injection-Related Adverse Events 67 -- Coagulation and Hypercoagulable States 69 -- Increased Susceptibility 70 -- Alterations in Brain Development 73 -- Contribution of Animal Models 76 -- References 79 -- 4 MEASLES, MUMPS, AND RUBELLA VACCINE 89 -- Introduction 89 -- Measles Inclusion Body Encephalitis 93 -- Encephalitis and Encephalopathy 95 -- Febrile Seizures 100 -- Afebrile Seizures 105 -- Meningitis 107 -- Ataxia 110 -- Autism 112 -- Acute Disseminated Encephalomyelitis 115 -- Transverse Myelitis 116 -- Optic Neuritis 117 -- Neuromyelitis Optica 119 -- Multiple Sclerosis Onset in Adults 120 -- Multiple Sclerosis Onset in Children 122 -- Guillain-Barré Syndrome 123 -- Chronic Inflammatory Disseminated Polyneuropathy 124 -- Opsoclonus Myoclonus Syndrome 125 -- Brachial Neuritis 125 -- Anaphylaxis 126 -- Transient Arthralgia in Women 130 -- Transient Arthralgia in Children 134 -- Chronic Arthralgia in Women 137 -- Chronic Arthritis in Women 140 -- Chronic Arthropathy in Children 143 -- Arthropathy in Men 144 -- Type 1 Diabetes 146 -- Hepatitis 149 -- Chronic Fatigue Syndrome 150 -- Fibromyalgia 151 -- Hearing Loss 151 -- References 196 -- 5 VARICELLA VIRUS VACCINE 211 -- Introduction 211 -- Disseminated Oka VZV Without Other Organ Involvement 213 -- Disseminated Oka VZV with Other Organ Involvement 219 -- Vaccine Strain Viral Reactivation Without Other Organ Involvement 224 -- Vaccine Strain Viral Reactivation with Other Organ Involvement 228 -- Encephalopathy 233 -- Seizures 233 -- Cerebellar Ataxia 235 -- Acute Disseminated Encephalomyelitis 236 -- Transverse Myelitis 237 -- Guillain-Barré Syndrome 238 -- Small Fiber Neuropathy 239 -- Anaphylaxis 239 -- Onset or Exacerbation of Arthropathy 242 -- Stroke 243 -- Thrombocytopenia 244 -- References 248 -- 6 INFLUENZA VACCINE 257 -- Introduction 257 -- Encephalitis and Encephalopathy 262 -- Seizures 264 -- Acute Disseminated Encephalomyelitis 267 -- Optic Neuritis 269 -- Neuromyelitis Optica 271 -- Multiple Sclerosis Onset in Adults 271 -- Multiple Sclerosis Relapse in Adults 273 -- Guillain-Barré Syndrome 275 -- Chronic Inflammatory Disseminated Polyneuropathy 281 -- Bell’s Palsy 282 -- Brachial Neuritis 284 -- Small Fiber Neuropathy 285 -- Anaphylaxis 285 -- Inactivated Influenza Vaccine and Asthma Exacerbation or Reactive Airway Disease -- Episodes in Children and Adults 288 -- Live Attenuated Influenza Vaccine and Asthma Exacerbation or Reactive Airway Disease -- Episodes in Children Younger Than 5 Years of Age 293 -- Live Attenuated Influenza Vaccine and Asthma Exacerbation or Reactive Airway Disease -- Episodes in Persons 5 Years of Age or Older 298 -- Onset or Exacerbation of Systemic Lupus Erythematosus 301 -- Onset or Exacerbation of Vasculitis 304 -- Polyarteritis Nodosa 306 -- Onset or Exacerbation of Arthropathy 307 -- Stroke 308 -- Myocardial Infarction 309 -- Fibromyalgia 311 -- All-Cause Mortality 311 -- Oculorespiratory Syndrome 313 -- References 354 -- 7 HEPATITIS A VACCINE 369 -- Introduction 369 -- Acute Disseminated Encephalomyelitis 370 -- Transverse Myelitis 371 -- Multiple Sclerosis 372 -- Guillain-Barré Syndrome 373 -- Chronic Inflammatory Disseminated Polyneuropathy 374 -- Bell’s Palsy 374 -- Anaphylaxis 375 -- Autoimmune Hepatitis 376 -- References 378 -- 8 HEPATITIS B VACCINE 381 -- Introduction 381 -- Encephalitis and Encephalopathy 383 -- Seizures 383 -- Acute Disseminated Encephalomyelitis 385 -- Transverse Myelitis 386 -- Optic Neuritis 387 -- Neuromyelitis Optica 389 -- Multiple Sclerosis Onset in Adults 390 -- Multiple Sclerosis Onset in Children 392 -- Multiple Sclerosis Relapse in Adults 394 -- Multiple Sclerosis Relapse in Children 395 -- First Demyelinating Event in Adults 396 -- First Demyelinating Event in Children 399 -- Guillain-Barré Syndrome 400 -- Chronic Inflammatory Disseminated Polyneuropathy 401 -- Brachial Neuritis 402 -- Anaphylaxis 402 -- Erythema Nodosum 403 -- Onset or Exacerbation of Systemic Lupus Erythematosus 404 -- Onset or Exacerbation of Vasculitis 406 -- Onset or Exacerbation of Polyarteritis Nodosa 409 -- Onset or Exacerbation of Psoriatic Arthritis 411 -- Onset or Exacerbation of Reactive Arthritis 412 -- Onset or Exacerbation of Rheumatoid Arthritis 414 -- Onset or Exacerbation of Juvenile Idiopathic Arthritis 416 -- Type 1 Diabetes 418 -- Fibromyalgia 420 -- References 431 -- 9 HUMAN PAPILLOMAVIRUS VACCINE 441 -- Introduction 441 -- Acute Disseminated Encephalomyelitis 442 -- Transverse Myelitis 443 -- Neuromyelitis Optica 444 -- Multiple Sclerosis 444 -- Guillain-Barré Syndrome 445 -- Chronic Inflammatory Disseminated Polyneuropathy 446 -- Brachial Neuritis 447 -- Amyotrophic Lateral Sclerosis 447 -- Anaphylaxis 449 -- Transient Arthralgia 450 -- Pancreatitis 451 -- Thromboembolic Events 452 -- Hypercoagulable States 453 -- References 455 -- 10 DIPHTHERIA TOXOID-, TETANUS TOXOID-, AND ACELLULAR PERTUSSISCONTAINING -- VACCINES 457 -- Introduction 457 -- Encephalitis and Encephalopathy 461 -- Infantile Spasms 464 -- Seizures 465 -- Ataxia 468 -- Autism 468 -- Acute Disseminated Encephalomyelitis 469 -- Transverse Myelitis 470 -- Optic Neuritis 471 -- Multiple Sclerosis Onset in Adults 472 -- Multiple Sclerosis Relapse in Adults 474 -- Multiple Sclerosis Relapse in Children 476 -- Guillain-Barré Syndrome 477 -- Chronic Inflammatory Disseminated Polyneuropathy 478 -- Opsoclonus Myoclonus Syndrome 480 -- Bell’s Palsy 480 -- Anaphylaxis 482 -- Chronic Urticaria 483 -- Serum Sickness 484 -- Arthropathy 485 -- Type 1 Diabetes 487 -- Myocarditis 490 -- Fibromyalgia 491 -- Sudden Infant Death Syndrome 491 -- Immune Thrombocytopenic Purpura 492 -- References 506 -- 11 MENINGOCOCCAL VACCINE 515 -- Introduction 515 -- Encephalitis and Encephalopathy 517 -- Acute Disseminated Encephalomyelitis 518 -- Transverse Myelitis 519 -- Multiple Sclerosis 519 -- Guillain-Barré Syndrome 520 -- Chronic Inflammatory Disseminated Polyneuropathy 521 -- Anaphylaxis 522 -- Chronic Headache 523 -- References 526 -- 12 INJECTION-RELATED ADVERSE EVENTS 529 -- Complex Regional Pain Syndrome 529 -- Deltoid Bursitis 531 -- Syncope 533 -- References 538 -- 13 CONCLUDING COMMENTS 541 -- References 545 Link for e-copy: http://www.nap.edu/catalog.php?record_id=13164 Format of e-copy: PDF [Open Access] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2712

An economic evaluation of varicella vaccination in Italian adolescents / Nancy Thiry in Vaccine, 22(2004)27-28 ([09/09/2004])  

[article] An economic evaluation of varicella vaccination in Italian adolescents [printed text] / Nancy Thiry, Author ; Philippe Beutels, Author ; Francesco Tancredi, Author ; A. Zanetti, Author ; Paolo Bonanni, Author ; Giovanni Gabutti, Author ; Pierre Van Damme, Author . - 2004 . - 3546-3562. Languages : English (eng) in Vaccine > 22(2004)27-28 [09/09/2004] . - 3546-3562 Descriptors: Classification W 1 Serials. Periodicals Indexation Adolescent ; Adult ; Age Factors ; Aged ; Chickenpox Vaccine ; Child ; Child, Preschool ; Cost of Illness ; Cost-Benefit Analysis ; Economics ; Encephalitis, Varicella Zoster ; Epidemiology ; Female ; Hospitalization ; Humans ; Italy ; Journal Article ; Male ; Markov Chains ; Mass Immunization ; Middle Aged ; Netherlands ; Peer Review ; prevention and control ; statistics and numerical data [Subheading] Abstract: An economic evaluation was performed to assess five varicella vaccination scenarios targeted to 11-year-old Italian adolescents. The scenarios were: "compulsory vaccination" of all adolescents, recommended vaccination of susceptible adolescents on the basis of an "anamnestic screening", a "blood test" or a combination of both ("both tests") and vaccination of adolescents in the private sector, at the parents' charge ("private vaccination"). Probabilities and unit costs were taken from published sources and experts opinion. The accuracy of the anamnestic screening (81.6% sensitivity and 87.3% specificity) was derived from a separate descriptive study among 344 Italian adolescents. The costs and benefits of each scenario were simulated using a Markov model and cost-effectiveness, budget-impact and cost-benefit analyses were conducted. Of all considered scenarios, "both tests" and "anamnestic screening" were the most appealing options with an estimated net direct cost of 5058 and 8929 per life-year gained (compared to no vaccination) versus 14,693-42,842 for the other scenarios. These two scenarios further resulted in substantial net savings for society (over 600,000 per cohort, BCR: 2.17). The need for a serological confirmation was highly dependent on the sensitivity of the anamnestic screening, which is believed to increase once such a program is launched. For practical considerations, "anamnestic screening" seems to be the most convenient option. Link for e-copy: http://tiny.cc/xktyn Format of e-copy: VDIC IP recognition Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1773 [article]

Applied longitudinal data analysis for epidemiology / Jos W. R. Twisk / Cambridge [U.K.] : Cambridge University Press (2003)

Applied longitudinal data analysis for epidemiology : a practical guide [printed text] / Jos W. R. Twisk, Author . - Cambridge [U.K.] : Cambridge University Press, 2003 . - XVI, 301 p. : ill. ; 25cm. ISBN : 978-0-521-81976-3 : 54,45 € Languages : English (eng) Descriptors: Classification WA 105 Epidemiology Indexation Data Interpretation, Statistical ; Epidemiologic Studies ; Epidemiology ; Longitudinal Studies ; Models, Statistical ; Statistical methods Abstract: In this book the most important techniques available for longitudinal data analysis are discussed. This discussion includes simple techniques such as the paired t-test and summary statistics, but also more sophisticated techniques such as generalised estimating equations and random coefficient analysis. A distinction is made between longitudinal analysis with continuous, dichotomous, and categorical outcome variables. It should be stressed that the emphasis of the discussion lies on the interpretation of the different techniques and on the comparison of the results of different techniques. Furthermore, special chapters will deal with the analysis of two measurements, experimental studies and the problem of missing data in longitudinal studies. Finally, an extensive overview of (and a comparison between) different software packages is provided. It is important to realise that this book is a practical guide and especially suitable for non-statisticians. • Clearly understandable by non-statisticians • Compares and contrasts different techniques and methods of analysis • Illustrated with examples of real-life research questions Contents note: 1. Introduction; 2. Study design; 3. Continuous outcome variables; 4. Continuous outcome variables - relationships with other variables; 5. Other possibilities to model longitudinal data; 6. Dichotomous outcome variables; 7. Categorical and 'count' outcome variables; 8. Longitudinal studies with two measurements: the definition and analysis of change; 9. Analysis of experimental studies; 10. Missing data in longitudinal studies; 11. Tracking; 12. Software for longitudinal data-analysis; 13. Sample size calculations; Index. Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=102

Hold

Place a hold on this item

Copies (1)

Barcode	Call number	Media type	Location	Section	Status
10273-00413	WA105/TWI	Book	KCE	Library (10.124)	Available

Assuétude aux médicaments / Pierre Chevalier / Bruxelles : Société Scientifique de Médecine Générale (SSMG) (2009)  

Assuétude aux médicaments [printed text] / Pierre Chevalier, Author ; Monique Debauche, Author ; Pascal Dereau, Author ; Daniel Duray, Author ; Jeannine Gailly, Author ; Dominique Paulus , Author ; Michel Vanhalewyn, Author . - Bruxelles : Société Scientifique de Médecine Générale (SSMG), 2009 . - 33 p. : ill. ; 30 cm. - (Recommandations de bonne pratique; 261 Suppl.) . € 0,00 Languages : French (fre) Descriptors: Indexation adverse effects ; Diagnosis ; Epidemiology ; Physician-Patient Relations ; Physicians, Family ; Practice Guideline [Publication type] ; Prescriptions, Drug ; Substance-Related Disorders ; Therapy Classification WM 270 Substance-related disorders Abstract: L’assuétude aux médicaments constitue un problème de santé publique pour lequel de nombreux acteurs sont concernés : le milieu hospitalier, les pharmaciens, les patients eux-mêmes et en première ligne, les médecins généralistes. Ces derniers sont en effet à la source de prescriptions de substances pour lesquelles à terme, les patients sont susceptibles de développer une assuétude. Dans ce contexte, cette recommandation met l’accent sur l’implication du médecin prescripteur dans le problème des assuétudes aux médicaments prescrits et principalement les psychotropes (sédatifs, tranquillisants, antidépresseurs, antipsychotiques) et les analgésiques. Contents note: 1.Introduction .5 -- 1.1.Importance du problème .5 -- 1.2.Objectifs et limites de la RBP .6 -- 2.Définitions .6 -- 3.Données épidémiologiques .7 -- 4.Physiopathologie .8 -- 5.Facteurs influençant le risque de développer une assuétude aux médicaments .8 -- 5.1.Situations à risque .8 -- 5.2.Médicaments comportant un risque .8 -- 5.3.Patients à risque .10 -- 5.4.Médecins à risque .11 -- 6.Évaluation des attentes des consommateurs .12 -- 7.Complications .12 -- 7.1.Complications médicales .12 -- 7.2.Complications psychosociales .13 -- 8.Évaluation de l’abus médicamenteux .13 -- 8.1.Le dépistage (screening) .13 -- 8.1.1.Identification de personnes à risque d’abus ou de dépendance à l’alcool ou à une autre substance .13 -- 8.1.2.Identification de patients à risque d’abus d’une substance .14 -- 8.1.3.Identification de patients à risque de dépendance aux opioïdes pour traiter une douleur chronique .14 -- 8.1.4.Utilisation du questionnaire CAGE .14 -- 8.2.Le diagnostic .14 -- 8.2.1.Critères du DSM-IV pour les troubles liés aux substances .15 -- 8.2.2.Recherche et évaluation de comportements suggérant une addiction chez des sujets -- recevant des traitements opioïdes à long terme pour une douleur chronique .16 -- 8.2.3.Évaluation du degré de dépendance aux benzodiazépines .16 -- 8.3.Approche clinique .16 -- 8.3.1.Anamnèse .16 -- 8.3.2.Évaluation de la motivation .16 -- 8.3.3.Examen clinique .17 -- 8.3.4.Évaluation de la santé mentale .17 -- 8.3.5.Complications .17 -- 8.3.6.Examens complémentaires .17 -- 8.3.7.Références spécialisées .17 -- 9.Traitement .18 -- 9.1.Opiacés .18 -- 9.2.Benzodiazépines .19 -- 9.2.1.Sevrage .19 -- 9.2.2.Envoi d’un courrier aux patients .20 -- 9.3.Antidépresseurs .20 -- 9.4.Antipsychotiques .21 -- 9.5.Interventions des autorités .21 -- 9.5.1.Contrôle des prescriptions de benzodiazépines .21 -- 9.5.2.Envoi aux médecins du profil de prescriptions de patients ciblés .21 -- 9.6.Soins intégrés, thérapie familiale et rôle du pharmacien .22 -- 9.7.Formation continue des médecins .23 -- 9.8.Suivi .23 -- 10.Prévention .23 -- 11.Conclusions et recommandations .25 -- 12.Notes .26 -- 13.Bibliographie .28 -- 14.Appendice: méthodologie .31 -- 14.1.Question clinique .31 -- 14.2.Recherche .31 -- 14.3.Sélection des articles .31 -- 15.Rédaction et édition .33 -- 16.Commanditaire .33 Link for e-copy: http://www.ssmg.be/new/files/RBP_Assuetude.pdf Format of e-copy: PDF (277 Kb) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1524

Hold

Place a hold on this item

Copies (1)

Barcode	Call number	Media type	Location	Section	Status
10273-01637	WM 270 / CHE	Report	KCE	Library (10.124)	Available

Behoeften en opvolging van patiënten met langdurige COVID / Diego Castanares-Zapatero / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)  

Behoeften en opvolging van patiënten met langdurige COVID : Synthese [printed text] / Diego Castanares-Zapatero , Author ; Laurence Kohn , Author ; Marie Dauvrin , Author ; Jens Detollenaere , Author ; Charline Maertens de Noordhout, Author ; Célia Primus-de Jong, Author ; Irina Cleemput , Author ; Koen Van Den Heede , Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2021 . - 38 p. : ill., ; A4. - (KCE Reports. Health Services Research (HSR); 244AS) . ISSN : D/2021/10.273/28 : € 0,00 Languages : Dutch (nla) Descriptors: Indexation 2020-04 ; COVID-19 [Supplementary Concept] ; Epidemiology ; Interviews ; Pathology ; R344 ; Surveys and Questionnaires Classification WC 506.5 COVID-19, Complications Abstract: Langdurige COVID treft zowel mensen die een ernstige vorm van COVID-19 hebben doorgemaakt, als mensen die een milde vorm hebben gehad. Alle leeftijdsgroepen kunnen worden getroffen, maar het komt het vaakst voor in de leeftijdsgroep 35-69 jaar. Zes maanden na een besmetting met het coronavirus heeft ten minste één op de zeven mensen nog steeds symptomen. Deze symptomen zijn zeer uiteenlopend en houden waarschijnlijk verband met een combinatie van verschillende mechanismen, die momenteel voornamelijk nog een hypothetisch karakter hebben. Het Federaal Kenniscentrum voor de Gezondheidszorg (KCE) heeft een uitgebreide online-enquête gehouden bij 1 320 mensen met langdurige COVID. Deze studie bevestigt dat langdurige COVID leidt tot een duidelijke vermindering van de levenskwaliteit, en vaak moeilijkheden oplevert bij de terugkeer naar het werk. De psychologische gevolgen zijn ernstig. Patiënten melden dat zij zich vaak verloren voelen in ons gezondheidszorgsysteem en dat er een gebrek is aan een globale aanpak van hun problemen. Het KCE stelt voor dat een globaal functioneel assessment (‘bilan’) van patiënten mogelijk gemaakt wordt, zodat zij kunnen worden doorverwezen naar de gepaste zorg op maat, die op een gecoördineerde wijze wordt georganiseerd. Dit "bilan" zou in gespecialiseerde centra plaatsvinden, maar de voorgeschreven behandeling en opvolging zou zoveel als mogelijk binnen de eerste lijn moeten plaatsvinden. Link for e-copy: https://kce.fgov.be/sites/default/files/atoms/files/KCE_344A_Langdurige_Covid_Sy [...] Format of e-copy: PDF (1,8 MB) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4785

Besoins et suivi des patients atteints de COVID long / Diego Castanares-Zapatero / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)  

Permalink

Borstklinieken / Belgische Interparlementaire Groep 'Borstkanker' (Belgium) / Brussel [Belgium] : Stichting tegen kanker = Fondation contre le cancer (2005)

Permalink

Cancer science / Gan Gakkai, Nihon / Oxford [England] : Wiley Publishing on behalf of the Japanese Cancer Association (2005)  

Permalink

Cijfers / Vlaams Agentschap Zorg en Gezondheid (VAZG) / Vlaams Agentschap Zorg en Gezondheid (VAZG) (2008)  

Permalink

Concepts of epidemiology / Raj S. Bhopal / Oxford University Press (2008)

Permalink

Correctie van refractieve oogafwijkingen bij volwassenen / Wendy Christiaens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)  

Permalink

Correction of refractive errors of the eye in adults / Wendy Christiaens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)  

Permalink

Correction of refractive errors of the eye in adults / Wendy Christiaens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)  

Permalink

Correction des troubles de la réfraction oculaire chez les adultes / Wendy Christiaens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)  

Permalink

CUGE / Ann Van den Bruel in Alcohol and alcoholism, 39(2004)5 ([08/02/2004])  

Permalink